RAC — Racura Oncology Cashflow Statement
0.000.00%
Last trade - 00:00- AU$310.77m
- AU$276.48m
- AU$3.42m
Annual cashflow statement for Racura Oncology, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | 2026 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Changes in Working Capital | -5.68 | -7.93 | -6.87 | -2.07 | -5.62 |
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -6.26 | -10.7 | -9.55 | -4.57 | -8.25 |
| Capital Expenditures | — | — | — | — | -0.004 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | 0 | 0 | 0 | 0.001 |
| Sale of Fixed Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | — | 0 | 0 | 0 | -0.003 |
| Financing Cash Flow Items | -0.463 | 0 | -0.005 | 0 | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Cash from Financing Activities | 30.5 | -1.28 | 5.21 | 1.06 | 28.9 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 24.2 | -12 | -4.33 | -3.52 | 20.6 |